Energenesis Biomedical CO.,Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 2.839 million compared to TWD 2.479 million a year ago. Operating loss was TWD 67.898 million compared to TWD 65.454 million a year ago. Net loss was TWD 66.083 million compared to TWD 64.584 million a year ago. Basic loss per share was TWD 1.12 compared to TWD 1.31 a year ago.